valproic acid and cyclin d1

valproic acid has been researched along with cyclin d1 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bacon, CL; Gallagher, HC; Haughey, JC; Regan, CM1
Desmond, JC; Gui, D; Koeffler, HP; Kumagai, T; Miyakawa, I; Said, JW; Takai, N; Whittaker, S1
Koistinen, P; Savolainen, ER; Siitonen, T1
Chen, H; Greenblatt, DY; Haymart, M; Jaskula-Sztul, R; Kunnimalaiyaan, M; Ning, L; Vaccaro, AM1
Zhang, ZH; Zhao, L; Zhu, CM1
Huang, K; Li, Y; Ma, L; Nie, D; Wang, X; Wu, Y; Xiao, J; Xie, S; Yin, S1
Baek, SS; Ji, ES; Kim, CJ; Kim, JE; Lee, SJ; Park, JK; Seo, TB; Shin, MS1
Boku, S; Inoue, T; Kato, A; Kitaichi, Y; Kusumi, I; Masuda, T; Nakagawa, S; Nishikawa, H; Omiya, Y; Takamura, N1
Bagci, G; Dodurga, Y; Gundogdu, G; Koc, T; Kucukatay, V; Satiroglu-Tufan, NL; Tekin, V1
Chai, YG; Cho, GW; Choi, MR; Han, DM; Jeong, SG; Jung, KH1
Gu, WP; Ma, XJ; Wang, YS; Zhao, X1

Other Studies

11 other study(ies) available for valproic acid and cyclin d1

ArticleYear
Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase.
    Journal of neurochemistry, 2002, Volume: 83, Issue:1

    Topics: Active Transport, Cell Nucleus; Animals; Anticonvulsants; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line; Cell Nucleus; Cyclin D1; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; G1 Phase; Glioma; Immunoblotting; Immunohistochemistry; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Rats; Tumor Suppressor Proteins; Valproic Acid

2002
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-01, Volume: 10, Issue:3

    Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cadherins; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Chromatin; Cyclin D1; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Dose-Response Relationship, Drug; Endometrial Neoplasms; Enzyme Inhibitors; Female; Flow Cytometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; In Situ Nick-End Labeling; Mice; Mice, Nude; Precipitin Tests; Proto-Oncogene Proteins c-bcl-2; S Phase; Sodium Oxybate; Time Factors; Tumor Suppressor Proteins; Valproic Acid; Vorinostat

2004
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells.
    Leukemia research, 2005, Volume: 29, Issue:11

    Topics: Butyrates; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Valproic Acid

2005
Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    The oncologist, 2007, Volume: 12, Issue:8

    Topics: Animals; Antineoplastic Agents; Carcinoid Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Cyclin D1; Gastrointestinal Neoplasms; Genes, Reporter; Humans; Luciferases; Lung Neoplasms; Male; Mice; Mice, Nude; Phenotype; Receptor, Notch1; RNA Interference; Signal Transduction; Valproic Acid; Xenograft Model Antitumor Assays

2007
[Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2008, Volume: 29, Issue:12

    Topics: Cell Cycle; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Histone Deacetylase Inhibitors; Humans; RNA, Messenger; Valproic Acid

2008
Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:12

    Topics: Acute Disease; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Cell Survival; Cyclin D1; Drug Synergism; Gene Expression; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid; Proteasome Inhibitors; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Valproic Acid

2012
Treadmill exercise ameliorates motor disturbance through inhibition of apoptosis in the cerebellum of valproic acid-induced autistic rat pups.
    Molecular medicine reports, 2013, Volume: 8, Issue:2

    Topics: Animals; Animals, Newborn; Apoptosis; Autistic Disorder; bcl-2-Associated X Protein; Caspase 3; Cell Adhesion Molecules, Neuronal; Cerebellum; Cyclin D1; Extracellular Matrix Proteins; Glutamate Decarboxylase; Male; Nerve Tissue Proteins; Physical Conditioning, Animal; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Rats; Reelin Protein; Serine Endopeptidases; Valproic Acid

2013
Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Animals; Antimanic Agents; beta Catenin; Cell Proliferation; Cyclin D1; Dentate Gyrus; Dexamethasone; Glucocorticoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Histone Deacetylase Inhibitors; Histone Deacetylases; Male; Neural Stem Cells; Phosphorylation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Valproic Acid

2014
Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
    Molecular biology reports, 2014, Volume: 41, Issue:7

    Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neurons; Signal Transduction; Transcription Factor RelA; Valproic Acid

2014
Proteomic analysis reveals KRIT1 as a modulator for the antioxidant effects of valproic acid in human bone-marrow mesenchymal stromal cells.
    Drug and chemical toxicology, 2015, Volume: 38, Issue:3

    Topics: Antioxidants; Blotting, Western; Bone Marrow Cells; Cells, Cultured; Cyclin D1; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Hydrogen Peroxide; KRIT1 Protein; Mesenchymal Stem Cells; Microtubule-Associated Proteins; Oxidants; Oxidative Stress; Proteomics; Proto-Oncogene Proteins; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superoxide Dismutase; Transfection; Up-Regulation; Valproic Acid

2015
The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells.
    Croatian medical journal, 2017, Oct-31, Volume: 58, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Proliferation; Cyclin D1; Cyclin E; Female; G1 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Humans; MCF-7 Cells; Oncogene Proteins; Signal Transduction; Valproic Acid

2017